Copy Development | Web Design | MOA | Corporate Deck
Back to Work
Aligos Therapeutics’ mission to become a leader in liver and viral disease therapies has driven the successful advancement of multiple drug candidates from discovery through commercialization — a legacy the company continues to build upon today. Grounded in a strong scientific foundation, Aligos has developed a differentiated pipeline of potential best-in-class therapies targeting significant unmet medical needs.
This evolution is reflected across the company’s newly launched corporate website, investor presentations, and mechanism-of-action (MOA) video, all designed to communicate Aligos’ science and vision with greater clarity and impact. In parallel, the recently launched B-Supreme clinical trial website introduces a custom designed visual identity, an interactive clinical trial site locator map, and integrated study information integrated directly from ClinicalTrials.gov.
